Competitive inhibition of brain hexokinase by metrizamide

John M. Bertoni, Charles G. Steinman

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

We compared the effect of metrizamide and its parent compound glucosamine on the kinetics of dog brain hexokinase. The Michaelis constant (Km) for glucose rose from 0.065 to 0.15 to 0.28 mM in the presence of 0, 16, and 32 mM metrizamide, respectively. For 0, 1.5, and 3.7 mM glucosamine, the Km values were 0.065, 0.4, and 1.3 mM. No change was found in the maximal velocity with either inhibitor. Metrizamide is therefore a rather weak competitive inhibitor of brain hexokinase. However, since the brain or spinal cord may be exposed to metrizamide concentrations near 780 mM during myelography, it is predictable that glucose metabolism may be significantly impaired under these conditions. This may be the mechanism for some cases of metrizamide encephalopathy.

Original languageEnglish (US)
Pages (from-to)320-323
Number of pages4
JournalNeurology
Volume32
Issue number3
StatePublished - Mar 1982

Fingerprint

Metrizamide
Hexokinase
Brain
Glucosamine
Glucose
Myelography
Brain Diseases
Spinal Cord
Dogs

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Competitive inhibition of brain hexokinase by metrizamide. / Bertoni, John M.; Steinman, Charles G.

In: Neurology, Vol. 32, No. 3, 03.1982, p. 320-323.

Research output: Contribution to journalArticle

Bertoni, JM & Steinman, CG 1982, 'Competitive inhibition of brain hexokinase by metrizamide', Neurology, vol. 32, no. 3, pp. 320-323.
Bertoni, John M. ; Steinman, Charles G. / Competitive inhibition of brain hexokinase by metrizamide. In: Neurology. 1982 ; Vol. 32, No. 3. pp. 320-323.
@article{3fd1be737e794756bd26b1f025213d3b,
title = "Competitive inhibition of brain hexokinase by metrizamide",
abstract = "We compared the effect of metrizamide and its parent compound glucosamine on the kinetics of dog brain hexokinase. The Michaelis constant (Km) for glucose rose from 0.065 to 0.15 to 0.28 mM in the presence of 0, 16, and 32 mM metrizamide, respectively. For 0, 1.5, and 3.7 mM glucosamine, the Km values were 0.065, 0.4, and 1.3 mM. No change was found in the maximal velocity with either inhibitor. Metrizamide is therefore a rather weak competitive inhibitor of brain hexokinase. However, since the brain or spinal cord may be exposed to metrizamide concentrations near 780 mM during myelography, it is predictable that glucose metabolism may be significantly impaired under these conditions. This may be the mechanism for some cases of metrizamide encephalopathy.",
author = "Bertoni, {John M.} and Steinman, {Charles G.}",
year = "1982",
month = "3",
language = "English (US)",
volume = "32",
pages = "320--323",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Competitive inhibition of brain hexokinase by metrizamide

AU - Bertoni, John M.

AU - Steinman, Charles G.

PY - 1982/3

Y1 - 1982/3

N2 - We compared the effect of metrizamide and its parent compound glucosamine on the kinetics of dog brain hexokinase. The Michaelis constant (Km) for glucose rose from 0.065 to 0.15 to 0.28 mM in the presence of 0, 16, and 32 mM metrizamide, respectively. For 0, 1.5, and 3.7 mM glucosamine, the Km values were 0.065, 0.4, and 1.3 mM. No change was found in the maximal velocity with either inhibitor. Metrizamide is therefore a rather weak competitive inhibitor of brain hexokinase. However, since the brain or spinal cord may be exposed to metrizamide concentrations near 780 mM during myelography, it is predictable that glucose metabolism may be significantly impaired under these conditions. This may be the mechanism for some cases of metrizamide encephalopathy.

AB - We compared the effect of metrizamide and its parent compound glucosamine on the kinetics of dog brain hexokinase. The Michaelis constant (Km) for glucose rose from 0.065 to 0.15 to 0.28 mM in the presence of 0, 16, and 32 mM metrizamide, respectively. For 0, 1.5, and 3.7 mM glucosamine, the Km values were 0.065, 0.4, and 1.3 mM. No change was found in the maximal velocity with either inhibitor. Metrizamide is therefore a rather weak competitive inhibitor of brain hexokinase. However, since the brain or spinal cord may be exposed to metrizamide concentrations near 780 mM during myelography, it is predictable that glucose metabolism may be significantly impaired under these conditions. This may be the mechanism for some cases of metrizamide encephalopathy.

UR - http://www.scopus.com/inward/record.url?scp=0020058611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020058611&partnerID=8YFLogxK

M3 - Article

C2 - 7199650

AN - SCOPUS:0020058611

VL - 32

SP - 320

EP - 323

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 3

ER -